We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+19.09%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.27B
AUM Growth
-$5.76B
Cap. Flow
-$1.51B
Cap. Flow %
-46.09%
Top 10 Hldgs %
34.23%
Holding
5,681
New
749
Increased
1,274
Reduced
3,081
Closed
446

Sector Composition

Rank Sector Weight
1 Technology 9.66%
2 Financials 8.46%
3 Healthcare 8.24%
4 Consumer Discretionary 7.74%
5 Industrials 6.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIR icon
3401
Vir Biotechnology
VIR
$1.52B
$37K ﹤0.01%
1,378
-43,664
-97% -$1.42M
WTI icon
3402
W&T Offshore
WTI
$546M
$37K ﹤0.01%
17,025
-135,705
-89% -$262K
XP icon
3403
XP
XP
$7.98B
$37K ﹤0.01%
938
-5,920
-86% -$242K
ZNTL icon
3404
Zentalis Pharmaceuticals
ZNTL
$297M
$37K ﹤0.01%
718
-8,516
-92% -$384K
LGTY
3405
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$37K ﹤0.01%
2,167
-29,307
-93% -$467K
AKTS
3406
DELISTED
Akoustis Technologies Inc
AKTS
$37K ﹤0.01%
3,046
-31,884
-91% -$280K
NGM
3407
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$37K ﹤0.01%
1,237
-4,953
-80% -$108K
APEN
3408
DELISTED
Apollo Endosurgery, Inc.
APEN
$37K ﹤0.01%
+11,060
New +$29.1K
ECOL
3409
DELISTED
US Ecology, Inc.
ECOL
$37K ﹤0.01%
1,018
-22,839
-96% -$791K
OSB
3410
DELISTED
Norbord Inc.
OSB
$37K ﹤0.01%
865
-197
-19% -$7.21K
NVIV
3411
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
$37K ﹤0.01%
+1,831
New +$35.8K
CHU
3412
DELISTED
China Unicom (HONG KONG) Limited
CHU
$37K ﹤0.01%
6,554
+2,133
+48% +$13.5K
ACIC icon
3413
American Coastal Insurance
ACIC
$465M
$36K ﹤0.01%
6,269
-16,784
-73% -$84.8K
API
3414
Agora
API
$408M
$36K ﹤0.01%
+903
New +$37.3K
CAC icon
3415
Camden National
CAC
$990M
$36K ﹤0.01%
1,004
-7,200
-88% -$247K
CTSO icon
3416
Cytosorbents Corp
CTSO
$23.3M
$36K ﹤0.01%
4,587
-32,633
-88% -$273K
DOMH icon
3417
Dominari Holdings
DOMH
$70.8M
$36K ﹤0.01%
+2,399
New +$23.9K
EAF icon
3418
GrafTech
EAF
$201M
$36K ﹤0.01%
334
-503
-60% -$40.4K
EPAC icon
3419
Enerpac Tool Group
EPAC
$1.91B
$36K ﹤0.01%
1,611
-55,219
-97% -$1.15M
EWG icon
3420
iShares MSCI Germany ETF
EWG
$1.67B
$36K ﹤0.01%
1,148
-372
-24% -$11.2K
FENC icon
3421
Fennec Pharmaceuticals
FENC
$414M
$36K ﹤0.01%
4,870
-15,937
-77% -$121K
FOR icon
3422
Forestar Group
FOR
$1.49B
$36K ﹤0.01%
1,788
-58,562
-97% -$1.11M
GAIA icon
3423
Gaia
GAIA
$30.8M
$36K ﹤0.01%
3,632
-10,224
-74% -$107K
GDEN
3424
DELISTED
Golden Entertainment
GDEN
$36K ﹤0.01%
1,785
-16,908
-90% -$272K
GNLN icon
3425
Greenlane Holdings
GNLN
$1.19M
0

Similar funds

Tower Research Capital (TRC)'s Q4 2020 Portfolio in Review

As of Q4 2020, Tower Research Capital (TRC) held 5,681 positions worth $3.27B, down 64% from $9.03B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $1.51B in Q4 2020, closing 446 positions and reducing 3,081 holdings. Its most notable exit was iShares Russell 2000 Growth ETF, an estimated $13.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 6.3% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 ETF worth $24.4M.

  • Tower Research Capital (TRC)'s largest Q4 2020 buy was iShares Russell 1000 ETF: 115,321 shares worth $24.4M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $99.8M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2020 reduction was iShares Russell 2000 ETF, cutting an estimated $36.3M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q4 2020, selling an estimated $13.7M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $3.27B portfolio in Q4 2020.
  • Tower Research Capital (TRC) opened 749 new positions and closed 446 in Q4 2020.
  • Tower Research Capital (TRC)'s portfolio value fell 64% quarter-over-quarter to $3.27B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2020, filed 16 Feb 2021.